ListarInstituto de Investigación Biomédica da Coruña (INIBIC) por tema "r-tPA treatment"
Mostrando ítems 1-1 de 1
-
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
(Elsevier, 2023-12-15)[Abstract] Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ...